The contraceptive use of depot medroxyprogesterone acetate.
Hickey
M
M
Sydney Centre for Reproductive Health Research, Australia.
Fraser
I
I
D000818:Animals; D001842:Bone and Bones / Q000187:drug effects; D001943:Breast Neoplasms / Q000139:chemically induced; D002986:Clinical Trials as Topic; D003271:Contraceptive Agents, Female / Q000009:adverse effects / Q000494:pharmacology*; D000075202:Contraindications; D004305:Dose-Response Relationship, Drug; D005260:Female; D005298:Fertility / Q000187:drug effects; D005833:Genital Neoplasms, Female / Q000139:chemically induced; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects / Q000494:pharmacology*; D008597:Menstrual Cycle / Q000187:drug effects; D014481:United States; D014486:United States Food and Drug Administration
D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate